ImmuCell Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
| Q1 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2025 | 1 | $0.05 | $0.05 | $0.05 |
| Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
ImmuCell Corporation Earnings Date And Information
ImmuCell Corporation last posted its earnings results on Thursday, May 13th, 2021. The company reported $-0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.11. The company had revenue of 6.01 B for the quarter and had revenue of 17.47 M for the year. ImmuCell Corporation has generated $-1 earnings per share over the last year ($-0.75 diluted earnings per share) and currently has a price-to-earnings ratio of -0.04. ImmuCell Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
ImmuCell Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$85.94 | $6.01 B | $6.01 B | ||
| 08/13/2024 | Q2 2024 | -$0.20 | $5.47 M | $5.47 M | ||
| 05/14/2024 | Q1 2024 | -$0.06 | $7.26 M | |||
| 04/01/2024 | Q4 2023 | -$0.15 | $5.10 M | |||
| 11/13/2023 | Q3 2023 | -$0.12 | $5.40 M | |||
| 08/10/2023 | Q2 2023 | -$0.18 | $3.53 M | |||
| 05/11/2023 | Q1 2023 | -$0.30 | $3.45 M | |||
| 03/29/2023 | Q4 2022 | -$0.22 | $3.91 M | |||
| 11/21/2022 | Q3 2022 | -$0.08 | $4.80 M | |||
| 08/11/2022 | Q2 2022 | -$0.09 | $3.86 M | |||
| 05/12/2022 | Q1 2022 | $0.09 | $6.00 M | |||
| 03/30/2022 | Q4 2021 | $0.01 | $5.44 M | |||
| 11/15/2021 | Q3 2021 | $0.02 | $3.59 M | $5.15 M | ||
| 08/12/2021 | Q2 2021 | $0.02 | $3.26 M | $4.54 M | ||
| 05/13/2021 | Q1 2021 | $0.05 | -$0.06 | -0.11 | $4.11 M | |
| 03/30/2021 | Q4 2020 | $0.03 | $3.74 M | |||
| 11/12/2020 | Q3 2020 | -$0.08 | -$0.04 | 0.04 | $3.27 M | $3.72 M |
| 08/12/2020 | Q2 2020 | -$0.10 | -$0.11 | -0.01 | $3.00 M | $2.97 M |
| 05/13/2020 | Q1 2020 | -$0.02 | $4.91 M | |||
| 03/27/2020 | Q4 2019 | -$0.06 | $3.63 M |
ImmuCell Corporation Earnings: Frequently Asked Questions
-
When is ImmuCell Corporation's earnings date?
ImmuCell Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
How can I listen to ImmuCell Corporation's earnings conference call?
The conference call for ImmuCell Corporation's latest earnings report can be listened to online.
-
How can I read ImmuCell Corporation's conference call transcript?
The conference call transcript for ImmuCell Corporation's latest earnings report can be read online.
-
How much revenue does ImmuCell Corporation generate each year?
ImmuCell Corporation (:ICCC) has a recorded annual revenue of $17.47 M.
-
How much profit does ImmuCell Corporation generate each year?
ImmuCell Corporation (:ICCC) has a recorded net income of $17.47 M. ImmuCell Corporation has generated $-0.75 earnings per share over the last four quarters.
-
What is ImmuCell Corporation's price-to-earnings ratio?
ImmuCell Corporation (:ICCC) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is 0.
